Related Experiment Video
Updated: Jul 5, 2026

10:16
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Radiobinding assay for detecting autoantibodies to single epitopes
Vito Lampasona1, Cristina Belloni, Sandra Piquer
1Diagnostica e Ricerca San Raffaele, San Raffaele Scientific Institute, Milano, Italy.
Journal of Immunological Methods
|May 27, 2008
Summary
A novel radiobinding assay (RBA) detects epitope-specific autoantibodies with high sensitivity. This method advances autoimmune disease characterization by precisely quantifying autoantibodies against specific epitopes, including a newly identified one.
Area of Science:
- Immunology
- Autoimmunity
- Assay Development
Background:
- Autoantibodies are key biomarkers in autoimmune diseases, with diverse targets aiding disease characterization.
- Accurate detection and quantification of epitope-specific autoantibodies are crucial for understanding disease progression.
Purpose of the Study:
- To develop a sensitive assay for detecting and quantifying epitope-specific autoantibodies.
- To validate the assay using a model antigen and apply it to type 1 diabetes patient sera.
Main Methods:
- In vitro synthesis of radio-labelled proteins by integrating peptide epitopes into a TrxA protein construct.
- Development and validation of a radiobinding assay (RBA) using an animal model (MOG(40-55) peptide immunization).
- Application of RBA to sera from type 1 diabetes patients and controls using IA-2 autoantigen epitopes.
Main Results:
- The RBA successfully detected epitope-specific autoantibodies against IA-2 in type 1 diabetes patients.
- A novel epitope (JM3) was identified, and the RBA demonstrated higher sensitivity than ELISA for certain epitopes.
- Mutagenesis studies revealed diverse residue requirements for antibodies targeting JM2 and JM3 epitopes.
Conclusions:
- The developed RBA is a highly sensitive and versatile method for identifying and quantifying epitope-specific autoantibodies.
- This assay strategy provides a powerful tool for advancing autoimmune disease research and diagnostics.
- The findings highlight the complexity of autoantibody epitope recognition and offer new avenues for biomarker discovery.

